0
selected
-
1.
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S, et al
Lancet. 2009;373((9674):):1532-42.
-
2.
Erythropoietin or darbepoetin for patients with cancer - meta-analysis based on individual patient data
Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke MJ, Weingart O, Kluge S, et al
Cochrane Database of Systematic Reviews. 2009;((3):):CD007303.
-
3.
Recombinant human erythropoiesis stimulating agents in cancer patients: individual patient data meta-analysis on behalf of the EPO IPD Meta-Analysis Collaborative Group
Bohlius J, Brillant C, Clarke M, Kluge S, Napoli M, Piper M, Rades Dirk, Ray-Coquard I, Schmidlin K, Schumacher M, et al
Blood. 2008;112((11):): Abstract No. 6 & Abstract No. 4675
